Stock listing
Genomtec Sa
Selected listing: A2QRTZ · LS · EUR · DE
Genomtec Sa (Lang & Schwarz: A2QRTZ), Health Technology. Latest release Jun 1, 2026: GMT: Net loss narrowed and revenue rose, but continued funding and market…
- Ticker
- Lang & Schwarz: A2QRTZ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Genomtec Sa
GMT: Net loss narrowed and revenue rose, but continued funding and market risks persist
June 1, 2026
GMT: Patent expansion, cost cuts, and narrowed loss set the stage for commercialization in 2026
April 30, 2026
GMT: Net loss persists as R&D spending rises; commercialization and funding remain critical
November 28, 2025
GMT: Net loss deepened to PLN 6.6M as R&D spending rose; commercialization still ahead
September 29, 2025
GMT: Genomtec's Q1 2025 loss widened as R&D ramped up, with commercialization still pending
May 29, 2025